ES2137310T3 - Vacuna contra una infeccion por streptococcus suis. - Google Patents

Vacuna contra una infeccion por streptococcus suis.

Info

Publication number
ES2137310T3
ES2137310T3 ES94201295T ES94201295T ES2137310T3 ES 2137310 T3 ES2137310 T3 ES 2137310T3 ES 94201295 T ES94201295 T ES 94201295T ES 94201295 T ES94201295 T ES 94201295T ES 2137310 T3 ES2137310 T3 ES 2137310T3
Authority
ES
Spain
Prior art keywords
against streptococcus
streptococcus suis
vaccine against
suis infection
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94201295T
Other languages
English (en)
Inventor
Antonius Arnoldus Chris Jacobs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2137310T3 publication Critical patent/ES2137310T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN POLIPEPTIDO DE LA BACTERIA STREPTOCOCCUS SUIS CON UN PESO MOLECULAR DE APROXIMADAMENTE 54 KD, CAPAZ DE INDUCIR LA NEUTRALIZACION DE ANTICUERPOS CONTRA STREPTOCOCCUS SUIS. LA INVENCION TAMBIEN SE REFIERE A UNA VACUNA CONTRA LA INFECCION DE STREPTOCOCCUS SUIS, Y UN METODO PARA LA PREPARACION DE TAL VACUNA.
ES94201295T 1993-05-17 1994-05-09 Vacuna contra una infeccion por streptococcus suis. Expired - Lifetime ES2137310T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93201401 1993-05-17

Publications (1)

Publication Number Publication Date
ES2137310T3 true ES2137310T3 (es) 1999-12-16

Family

ID=8213828

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94201295T Expired - Lifetime ES2137310T3 (es) 1993-05-17 1994-05-09 Vacuna contra una infeccion por streptococcus suis.

Country Status (13)

Country Link
US (1) US5612042A (es)
EP (1) EP0626452B1 (es)
JP (1) JP3578799B2 (es)
AT (1) ATE183241T1 (es)
CZ (1) CZ289302B6 (es)
DE (1) DE69419966T2 (es)
DK (1) DK0626452T3 (es)
ES (1) ES2137310T3 (es)
GR (1) GR3031698T3 (es)
HU (1) HU218154B (es)
PL (1) PL177219B1 (es)
SK (1) SK281324B6 (es)
TW (1) TW494103B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI93733C (fi) * 1993-01-29 1995-05-26 Kaarina Tikkanen Streptococcus suis-bakteerin adhesiiniproteiini ja menetelmä sen valmistamiseksi
US5919466A (en) * 1993-10-01 1999-07-06 Gerbu Biotechnik Gmbh Method for improving the yield of immunoantibodies in the vaccination of animals and humans
AU709920B2 (en) * 1995-06-08 1999-09-09 University Of Saskatchewan Camp factor of streptococcus uberis
US5863543A (en) * 1996-06-05 1999-01-26 University Of Saskatchewan Camp factor of streptococcus uberis
US6936259B2 (en) 1995-06-08 2005-08-30 University Of Saskatchewan CAMP factor of Streptococcus uberis
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
FR2791895B1 (fr) * 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
EP1328543B1 (en) * 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups a & b
NO318426B1 (no) 2001-10-02 2005-04-18 Neurozym Biotech As Et materiale for a senke konsentrasjonen av patogene tarmpeptider
DE10239629A1 (de) * 2002-08-23 2004-04-08 Idt Impfstoffwerk Dessau-Tornau Gmbh Nicht-rekombinate Subunit-Vakzine gegen Streptococcus suis-Infektionen des Schweines
WO2007126816A2 (en) * 2006-03-30 2007-11-08 Embrex, Inc. Methods and compositions for vaccination of poultry
US7572457B2 (en) * 2006-03-31 2009-08-11 Wisconsin Alumni Research Foundation Use of Streptococcus suis 38 kDa polypeptide as an immunogen
JP5339243B2 (ja) * 2008-04-24 2013-11-13 株式会社微生物化学研究所 ストレプトコッカス・スイス感染症予防用ワクチン
TW201043242A (en) * 2009-03-26 2010-12-16 Intervet Int Bv Vaccine for protection against Streptococcus suis bacteria of various serotypes
WO2017005913A1 (en) 2015-07-09 2017-01-12 Intervacc Ab Vaccine against s.suis infection
CA3000201A1 (en) * 2015-10-07 2017-04-13 Boehringer Ingelheim Vetmedica, Inc. Streptococcus suis polysacchari de-protein conjugate composition
GB201703529D0 (en) * 2017-03-06 2017-04-19 Cambridge Entpr Ltd Vaccine composition
CN113957057B (zh) * 2021-11-16 2023-10-20 西南大学 一种杂交瘤细胞、能中和猪溶素的单克隆抗体及检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059419A (en) * 1988-06-09 1991-10-22 Grand Laboratories, Inc. Streptococcus suis antiserum and its use in treating Streptococcus suis infections

Also Published As

Publication number Publication date
SK281324B6 (sk) 2001-02-12
EP0626452B1 (en) 1999-08-11
HU218154B (hu) 2000-06-28
US5612042A (en) 1997-03-18
TW494103B (en) 2002-07-11
HU9401511D0 (en) 1994-08-29
GR3031698T3 (en) 2000-02-29
JP3578799B2 (ja) 2004-10-20
CZ117594A3 (en) 1995-02-15
HUT69796A (en) 1995-09-28
DE69419966T2 (de) 2000-01-20
JPH0710774A (ja) 1995-01-13
EP0626452A1 (en) 1994-11-30
SK56394A3 (en) 1995-07-11
PL303482A1 (en) 1994-12-12
DE69419966D1 (de) 1999-09-16
CZ289302B6 (cs) 2001-12-12
DK0626452T3 (da) 2000-02-14
ATE183241T1 (de) 1999-08-15
PL177219B1 (pl) 1999-10-29

Similar Documents

Publication Publication Date Title
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
BR0113822A (pt) Vacina
DE60125797D1 (de) Impfstoffzusammesetzung
BR0009166A (pt) Vacina
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
DK472988D0 (da) Terapeutiske praeparater mod streptokokinfektioner, transformerede vaerter og produkter fremstillet ved genteknologi
EP0090581A3 (en) Small peptides with the specificity of foot and mouth disease viral antigens
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
BR0009663A (pt) Composições de vacinas antibacterianas
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
EA200100700A1 (ru) Гены и белки и их применение
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
ES2087111T5 (es) Vacuna sintetica para la induccion especifica de linfocitos t citotoxicos.
NZ235316A (en) Vaccine containing capsular polysaccharide conjugated to recombinant c protein of a group b streptococcus, production and use against b streptococcus infection
WO1997025071A3 (en) Immunoconjugate for the treatment of aids
HUP9801572A2 (hu) Chlamydia-vakcinák
SE9500418L (sv) Nya försvagade Pseudomonas aerugionos stammar
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
ATE318300T1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
TW223019B (es)
ES2102836T3 (es) El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural.
ATE103817T1 (de) Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobulin-g-haeltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen.
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline
DE60022995D1 (de) Impfstoff
MX9202293A (es) Composicion de vacuna no-irritante.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 626452

Country of ref document: ES